Results 281 to 290 of about 562,738 (359)

Cerebrospinal Fluid Biomarkers Profiling in Cerebral Amyloid Angiopathy and Relationship With Disease Phenotypes. [PDF]

J Am Heart Assoc
Losa M, Ramusino MC, Cama I, Gualco L, Gandoglia I, Massa F, Donniaquio A, Mortola P, Argenti L, Lombardo L, Kreshpa W, Pelagotti V, Bozzo G, Orso B, Mattioli P, Arnaldi D, Cirone A, Ali S, Hamedani M, Pulze M, Plantone D, Lorenzini L, Falcitano L, Mazzacane F, Perini G, Costa A, Piana M, Castellan L, Uccelli A, Schenone A, Kozberg M, Piazza F, Del Sette M, Garbarino S, Roccatagliata L, Farina LM, Pardini M.   +36 more
europepmc   +1 more source

Analysis of Single Particles of Amyloid Beta and α‐Synuclein With Seeded Amplification for the Diagnosis of Alzheimer's and Parkinson's Disease

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Neurodegenerative diseases, including Alzheimer's disease (AD) and Parkinson's disease (PD), are characterized by the pathological aggregation of specific proteins such as amyloid beta (Aβ) and α‐synuclein, respectively. Early detection of these protein aggregates in biological fluids could facilitate timely diagnosis and therapeutic ...
Alexandra Dybala, Marlene Pils, Oliver Bannach, Gültekin Tamgüney, Detlev Riesner   +4 more
wiley   +1 more source

Uncommon cells in cerebrospinal fluid in Japanese encephalitis: A case report. [PDF]

Medicine (Baltimore)
Hou Y, Yang X.
europepmc   +1 more source

5‐Methylcytosine Analysis of miRNAs in Minimal Change Disease

Biotechnology and Applied Biochemistry, EarlyView.
ABSTRACT Minimal change disease (MCD) is a glomerular disorder, which is the most common cause of nephrotic syndrome in children. Additionally, the prevalence of MCD in adults has been increasing in recent years. During protein synthesis, noncoding RNAs can be regulated through a variety of modifications, which helps preserve biological diversity and ...
Huiyi Zeng, Dandan Li, Yunyi Li, Chen Yun, Xinzhou Zhang, Wenyu Gong, Mengyun Xiao, Haitao Li, Zhipeng Zeng, Ruqi Tan, Yishen Yang, Shaodong Luan, Yong Dai, Lianghong Yin, Donge Tang   +14 more
wiley   +1 more source

A new Principle of Thyroxine (T4) and Triiodo-thyronin (T3) Radioimmunoassay in unextracted Serum using Antisera with binding Optima at extreme pH ranges [PDF]

, 1980
Gärtner, Roland, Horn, K., Kewenig, R. M., Scriba, Peter Christian   +3 more
core  

A hitchhiker's guide to cerebrospinal fluid biomarkers for neuro-oncology. [PDF]

Neuro Oncol
Riviere-Cazaux C, Keough MB, Zuccato JA, Kumar R, Schulz S, Warrington AE, Ruff MW, Ellingson BM, Sanai N, Campian JL, Kizilbash SH, Parney IF, Zadeh G, Khasraw M, Kessler T, Sener U, Cahill DP, Mansouri A, Burns TC.   +18 more
europepmc   +1 more source

Age‐related differences in hydroxychloroquine‐associated adverse events: A pharmacovigilance study based on the FDA Adverse Event Reporting System

British Journal of Clinical Pharmacology, EarlyView.
Aims This real‐world pharmacovigilance study utilizes FDA Adverse Event Reporting System (FAERS) data (2004–2024) to characterize age‐related disparities in hydroxychloroquine (HCQ)‐associated adverse events (AEs), addressing gaps in age‐stratified risk assessment. Methods Disproportionality analysis (reporting odds ratios, RORs) and parametric Weibull
Guanghan Sun, Jingrong Yang, Lei Wan, Xia Xu, Jing Wang   +4 more
wiley   +1 more source

A prospective observational study of inflammatory mediators in cerebrospinal fluid after intraoperative radiotherapy of brain tumors. [PDF]

Ther Adv Med Oncol
Shiban E, Krauss P, Schaller T, Konietzko I, Mögele T, Jungbäck N, Mielke D, Märkl B, Kahl KH, Mielewczyk Z, Liesche-Starnecker F.   +10 more
europepmc   +1 more source

Delivery strategies of messenger RNA therapeutics for brain disorders

Bulletin of the Korean Chemical Society, EarlyView.
Thus, mRNA therapeutics offer a powerful new avenue for the treatment of brain diseases. This review examines strategies to bypass biological barriers, particularly the blood–brain barrier, and explores emerging delivery systems, such as direct intracerebral injection, intracerebroventricular injection, systemic delivery (including intravenous ...
Kounghwa Youn, Sunmin Oh, Hyunchae Gil, Yongseok Choi, Gyochang Keum, Eun‐Kyoung Bang   +5 more
wiley   +1 more source

Alterations in Cerebrospinal Fluid Density Following Contrast Administration in Patients With Acute Ischemic Stroke. [PDF]

Eur J Neurol
Khasminsky V, Naftali J, Tsur G, Barnea R, Eliahou R, Atar E, Auriel E.   +6 more
europepmc   +1 more source